Indication

Polyarticular juvenile idiopathic arthritis

Polyarticular juvenile idiopathic arthritis is a chronic inflammatory autoimmune disorder characterized by arthritis involving five or more joints during the first six months of disease onset in patients under 16 years of age. Read more about Polyarticular juvenile idiopathic arthritis

216 drugs 94 manufacturers

Advertisement

Drugs that treat it

Common Polyarticular juvenile idiopathic arthritis therapies.

Showing 64–72 of 216 drugs

KEVZARA (sarilumab)

MONOCLONAL ANTIBODY, HUMAN INTERLEUKIN 6 INHIBITORS·RHEUMATOID ARTHRITIS·+2
Sanofi-Aventis U.S.
Filter & compare in the drug finder →Opens the drug finder with Polyarticular juvenile idiopathic arthritis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Polyarticular juvenile idiopathic arthritis.

Polyarticular juvenile idiopathic arthritis is a chronic inflammatory autoimmune disorder characterized by arthritis involving five or more joints during the first six months of disease onset in patients under 16 years of age.

Primarily affecting the musculoskeletal system, it drives persistent synovial inflammation, effusion, pain, stiffness, and joint swelling that frequently follows a symmetric distribution involving both large joints and small joints of the hands and feet.

The condition is pathologically classified into rheumatoid factor–positive and rheumatoid factor–negative subtypes, with the seropositive form closely resembling adult rheumatoid arthritis and carrying a higher risk of progressive cartilage destruction, bone erosion, and functional impairment.

Personalize your experience

Follow Polyarticular juvenile idiopathic arthritis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it